Walid Gellad, MD, MPH
CHERP COIN Investigator
Staff Physician, VA Pittsburgh Healthcare System
Associate Professor of Medicine, University of Pittsburgh School of Medicine
Associate Professor of Health Policy and Management, University of Pittsburgh Graduate School of Public Health
Co-Director, Center for Pharmaceutical Policy and Prescribing
Profile
Dr. Gellad's research focuses on physician prescribing practices and on policy issues affecting access and adherence to medications for patients. He was the recipient of a career development award from the Department of Veterans Affairs to study the quality and efficiency of prescribing in the VA and is currently funded by the VA, NIH, CDC, and the state of Pennsylvania on multiple studies of pharmaceutical policy and prescription use. His work spans clinical areas, from diabetes, to hepatitis c, to prescription drug and substance abuse. His policy area of expertise is prescription drug pricing and spending. He is a former member of the Food and Drug Administration (FDA) advisory committee on nonprescription drugs and currently an alternate member of the FDA Drug Safety Oversight Board.
Dr. Gellad is also a nationally recognized authority on improving the measurement of medication adherence. In 2015, he founded and chaired the first national conference focused on improving the science behind medication adherence measurement.
Dr. Gellad is board certified in internal medicine and completed a residency and chief residency in internal medicine at Brigham and Women's Hospital and Harvard Medical School. He sees primary care patients in the VA Pittsburgh Heathcare System and attends on the inpatient general medical service.
News of Note
Dr. Gellad was honored with a 2019 Presidential Early Career Award for Scientists and Engineers.
Read profile of Dr. Gellad in Genetic Engineering & Biotechnology News
Funded Research
STORM Implementation Program Evaluation (SDR 16-193) as Principal Investigator
Published Research
Deintensification of Diabetes Medications among Veterans at the End of Life in VA Nursing Homes. Journal of the American Geriatrics Society (2020)Racial/Ethnic Differences in the Medical Treatment of Opioid Use Disorders Within the VA Healthcare System Following Non-Fatal Opioid Overdose. J Gen Intern Med (2020)
Incidence and Predictors of Aspirin Discontinuation in Older Adult Veteran Nursing Home Residents at End of Life. Journal of the American Geriatrics Society (2020)
Brand-name prescription drug use among diabetes patients in the VA and Medicare Part D. Ann Intern Med (2013)
The impact of family caregivers on potentially inappropriate medication use in non-institutionalized older adults with dementia. Am J Geriatr Pharmacother (2012)
Research Areas
- Pharmacy Policy
- Physician Prescribing Practices
